Puerperal infection after cesarean delivery: Evaluation of a standardized protocol

Objective: Our goal was to evaluate an antibiotic protocol for treatment of postcesarean endometritis. Study Design: Endometritis was diagnosed as a persistent fever ≥100.4°F beyond 24 hours after cesarean delivery and one or more of the following: uterine tenderness, tachycardia, foul lochia, or le...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2000-05, Vol.182 (5), p.1147-1151
Hauptverfasser: Brumfield, Cynthia G., Hauth, John C., Andrews, William W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: Our goal was to evaluate an antibiotic protocol for treatment of postcesarean endometritis. Study Design: Endometritis was diagnosed as a persistent fever ≥100.4°F beyond 24 hours after cesarean delivery and one or more of the following: uterine tenderness, tachycardia, foul lochia, or leukocytosis. Antibiotic therapy included gentamicin plus clindamycin and ampicillin (or vancomycin) as a triple antimicrobial in 148 women. Antibiotic failure was defined as persistent fever after 5 days of antibiotics and 72 hours of triple antibiotics. Results: Between 1993 and 1996, 322 of 1643 (20%) women were diagnosed with postcesarean endometritis. One hundred seventy-four patients (54%) were cured with clindamycin-gentamicin, and 129 who additionally received ampicillin or vancomycin (40%) were cured. Nineteen of the 322 (6%) women had persistent fever despite triple antibiotics. Of these, 6 had a wound complication, 12 were suspected to have antimicrobial resistance, and 1 had an infected hematoma. Conclusion: A prospective protocol consisting of clindamycin-gentamicin plus the selective addition of ampicillin or vancomycin cured 303 of 322 (94%) women with postcesarean endometritis. (Am J Obstet Gynecol 2000;182:1147-51.)
ISSN:0002-9378
1097-6868
DOI:10.1067/mob.2000.103249